Cargando…

Therapeutic Effect of Novel Cyanopyrrolidine-Based Prolyl Oligopeptidase Inhibitors in Rat Models of Amnesia

Prolyl oligopeptidase (POP) is a large cytosolic serine peptidase that is altered in patients with Alzheimer’s disease, Parkinsonian syndrome, muscular dystrophies, and other denervating diseases. Thus, POP may represent a relevant therapeutic target for treatment of neuropsychiatric disorders and n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zolotov, Nikolay N., Schepetkin, Igor A., Voronina, Tatyana A., Pozdnev, Vladimir F., Khlebnikov, Andrei I., Krylova, Irina V., Quinn, Mark T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727363/ https://www.ncbi.nlm.nih.gov/pubmed/35004610 http://dx.doi.org/10.3389/fchem.2021.780958

Ejemplares similares

The role of prolyl oligopeptidase, understanding the puzzle
por: García-Horsman, J. Arturo
Publicado: (2020)

Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis
por: Tenorio-Laranga, Jofre, et al.
Publicado: (2010)

Prolyl Oligopeptidase, Inositol Phosphate Signalling and Lithium Sensitivity
por: Harwood, Adrian J
Publicado: (2011)

Kinetic Landscape of a Peptide Bond-Forming Prolyl Oligopeptidase
por: Czekster, Clarissa M., et al.
Publicado: (2017)

Intrinsic basis of thermostability of prolyl oligopeptidase from Pyrococcus furiosus
por: Banerjee, Sahini, et al.
Publicado: (2021)

Crystal Structures of Trypanosoma brucei Oligopeptidase B Broaden the Paradigm of Catalytic Regulation in Prolyl Oligopeptidase Family Enzymes
por: Canning, Peter, et al.
Publicado: (2013)

Cyclotides Isolated From Violet Plants of Cameroon Are Inhibitors of Human Prolyl Oligopeptidase
por: Gattringer, Jasmin, et al.
Publicado: (2021)

The Dipeptidyl Peptidase Family, Prolyl Oligopeptidase, and Prolyl Carboxypeptidase in the Immune System and Inflammatory Disease, Including Atherosclerosis
por: Waumans, Yannick, et al.
Publicado: (2015)

Distribution, classification, domain architectures and evolution of prolyl oligopeptidases in prokaryotic lineages
por: Kaushik, Swati, et al.
Publicado: (2014)

Removal of prolyl oligopeptidase reduces alpha-synuclein toxicity in cells and in vivo
por: Svarcbahs, Reinis, et al.
Publicado: (2018)

The MSDIN family in amanitin-producing mushrooms and evolution of the prolyl oligopeptidase genes
por: Luo, Hong, et al.
Publicado: (2018)

Inhibition of Prolyl Oligopeptidase Prevents Consequences of Reperfusion following Intestinal Ischemia
por: Filippone, Alessia, et al.
Publicado: (2021)

Prolyl Oligopeptidase From Leishmania infantum: Biochemical Characterization and Involvement in Macrophage Infection
por: Lasse, Camila, et al.
Publicado: (2020)

2-Imidazole as a Substitute for the Electrophilic Group Gives Highly Potent Prolyl Oligopeptidase Inhibitors
por: Pätsi, Henri T., et al.
Publicado: (2021)

Exploration of the One-Bead One-Compound Methodology for the Design of Prolyl Oligopeptidase Substrates
por: Comellas, Gemma, et al.
Publicado: (2009)

Analysis of salt-bridges in prolyl oligopeptidase from Pyrococcus furiosus and Homo sapiens
por: Bandyopadhyay, Amal Kumar, et al.
Publicado: (2019)

Cholinesterase and Prolyl Oligopeptidase Inhibitory Activities of Alkaloids from Argemone platyceras (Papaveraceae)
por: Siatka, Tomáš, et al.
Publicado: (2017)

Prolyl oligopeptidase inhibition ameliorates experimental pulmonary fibrosis both in vivo and in vitro
por: Cucinotta, Laura, et al.
Publicado: (2023)

Oximes: Novel Therapeutics with Anticancer and Anti-Inflammatory Potential
por: Schepetkin, Igor A., et al.
Publicado: (2021)

Suppression of Tumor Growth in Mice by Rationally Designed Pseudopeptide Inhibitors of Fibroblast Activation Protein and Prolyl Oligopeptidase()
por: Jackson, Kenneth W., et al.
Publicado: (2015)

Parasite Prolyl Oligopeptidases and the Challenge of Designing Chemotherapeuticals for Chagas Disease, Leishmaniasis and African Trypanosomiasis
por: Bastos, I.M.D, et al.
Publicado: (2013)

Mycobacterium tuberculosis Prolyl Oligopeptidase Induces In vitro Secretion of Proinflammatory Cytokines by Peritoneal Macrophages
por: Portugal, Brina, et al.
Publicado: (2017)

Prolyl Oligopeptidase Inhibition Attenuates Steatosis in the L02 Human Liver Cell Line
por: Zhou, Da, et al.
Publicado: (2016)

Methotrexate and Cyclosporine Treatments Modify the Activities of Dipeptidyl Peptidase IV and Prolyl Oligopeptidase in Murine Macrophages
por: Olivo, R. A., et al.
Publicado: (2008)

Therapeutic Effects of Tryptanthrin and Tryptanthrin-6-Oxime in Models of Rheumatoid Arthritis
por: Kirpotina, Liliya N., et al.
Publicado: (2020)

Prolyl Oligopeptidase from the Blood Fluke Schistosoma mansoni: From Functional Analysis to Anti-schistosomal Inhibitors
por: Fajtová, Pavla, et al.
Publicado: (2015)

Computer-Aided Drug Discovery Identifies Alkaloid Inhibitors of Parkinson's Disease Associated Protein, Prolyl Oligopeptidase
por: Kulkarni, Apoorva M., et al.
Publicado: (2021)

KYP-2047, an Inhibitor of Prolyl-Oligopeptidase, Reduces GlioBlastoma Proliferation through Angiogenesis and Apoptosis Modulation
por: Scuderi, Sarah Adriana, et al.
Publicado: (2021)

Inhibition of Human Prolyl Oligopeptidase Activity by the Cyclotide Psysol 2 Isolated from Psychotria solitudinum
por: Hellinger, Roland, et al.
Publicado: (2015)

Diversity of MSDIN family members in amanitin-producing mushrooms and the phylogeny of the MSDIN and prolyl oligopeptidase genes
por: He, Zhengmi, et al.
Publicado: (2020)

Directed-Mutagenesis of Flavobacterium meningosepticum Prolyl-Oligopeptidase and a Glutamine-Specific Endopeptidase From Barley
por: Osorio, Claudia E., et al.
Publicado: (2020)

Prolyl Oligopeptidase Regulates Dopamine Transporter Oligomerization and Phosphorylation in a PKC- and ERK-Independent Manner
por: Julku, Ulrika H., et al.
Publicado: (2021)

The Protective Role of Prolyl Oligopeptidase (POP) Inhibition in Kidney Injury Induced by Renal Ischemia–Reperfusion
por: Casili, Giovanna, et al.
Publicado: (2021)

Effects of a Natural Prolyl Oligopeptidase Inhibitor, Rosmarinic Acid, on Lipopolysaccharide-Induced Acute Lung Injury in Mice
por: Chu, Xiao, et al.
Publicado: (2012)

Synergistic Pulmonoprotective Effect of Natural Prolyl Oligopeptidase Inhibitors in In Vitro and In Vivo Models of Acute Respiratory Distress Syndrome
por: Zerikiotis, Stelios, et al.
Publicado: (2023)

Structural Analysis of Prolyl Oligopeptidases Using Molecular Docking and Dynamics: Insights into Conformational Changes and Ligand Binding
por: Kaushik, Swati, et al.
Publicado: (2011)

The Inhibition of Prolyl Oligopeptidase as New Target to Counteract Chronic Venous Insufficiency: Findings in a Mouse Model
por: Casili, Giovanna, et al.
Publicado: (2020)

The protective role of prolyl oligopeptidase (POP) inhibition in acute lung injury induced by intestinal ischemia-reperfusion
por: Casili, Giovanna, et al.
Publicado: (2021)

Prolyl oligopeptidase inhibition reduces alpha‐synuclein aggregation in a cellular model of multiple system atrophy
por: Cui, Hengjing, et al.
Publicado: (2021)

Inhibition of Prolyl Oligopeptidase Restores Prohibitin 2 Levels in Psychosis Models: Relationship to Cognitive Deficits in Schizophrenia
por: Vila, Èlia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0nvijn1im93g9i349ltb8s0qp8